|
280
|
944
|
3zurA |
Crystal structure of an engineered botulinum neurotoxin type a- snare23 derivative, lc0-a-snap25-hn-a |
|
105
|
413
|
3rsjA |
Structure of hcrf in complex with ganglioside gd1a |
|
89
|
415
|
3rmxA |
Crystal structure of hcr/d f1240a mutant |
|
97
|
415
|
3rmyA |
Crystal structure of hcr/d w1238a mutant |
|
121
|
426
|
5v8pA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
127
|
426
|
5v8uA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
133
|
430
|
5v8rA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
104
|
424
|
5tpbA |
Binding domain of bont/a complexed with ganglioside variant |
|
110
|
425
|
5tpcA |
Binding domain of bont/a complexed with ganglioside |
|
135
|
423
|
4zjxA |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a novel cyclic peptide inhibitor |
|
117
|
442
|
5bqmA |
Crystal structure of sxn101959, a clostridium botulinum neurotoxin type d derivative and targeted secretion inhibitor |
|
103
|
430
|
4kbbA |
Structure of botulinum neurotoxin b binding domain in complex with both synaptotagmin ii and gd1a |
|
132
|
428
|
4ktxA |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 167-174 stretch |
|
141
|
428
|
4ks6A |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 166-174 stretch |
|
144
|
426
|
4kufA |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134 mutant with mtsea modified cys-165 causing stretch disorder |
|
100
|
421
|
4iqpA |
Crystal structure of hcra-w1266a |
|
93
|
421
|
4jraA |
Crystal structure of the botulinum neurotoxin a receptor-binding domain in complex with the luminal domain of sv2c |
|
120
|
427
|
4hevA |
Clostridium botulinum serotype a light chain inhibited by adamantane hydroxamate |
|
99
|
428
|
3r4uA |
Cell entry of botulinum neurotoxin type c is dependent upon interaction with two ganglioside molecules |
|
143
|
423
|
3qw5A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrgf |
|
94
|
428
|
3r4sA |
Cell entry of botulinum neurotoxin type c is dependent upon interaction with two ganglioside molecules |
|
146
|
422
|
3qw7A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrfc |
|
138
|
422
|
3qw8A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor crgc |
|
123
|
420
|
3qiyA |
Crystal structure of bont/a lc complexed with hydroxamate-based inhibitor pt-1 |
|
144
|
422
|
3qw6A |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rygc |
|
133
|
420
|
3qizA |
Crystal structure of bont/a lc complexed with hydroxamate-based inhibitor pt-2 |
|
131
|
419
|
3qj0A |
Crystal structure of bont/a lc complexed with hydroxamate-based inhibitor pt-3 |
|
130
|
419
|
3qixA |
Crystal structure of bont/a lc with zinc bound |
|
108
|
414
|
3oggA |
Crystal structure of the receptor binding domain of botulinum neurotoxin d |
|
112
|
420
|
3obrA |
Crystal structure of botulinum neurotoxin serotype d binding domain |
|
104
|
420
|
3obtA |
Crystal structure of botulinum neurotoxin serotype d ligand binding domain in complex with n-acetylneuraminic acid |
|
91
|
424
|
3n7kA |
Crystal structure of botulinum neurotoxin serotype c1 binding domain |
|
94
|
415
|
3n7jA |
Crystal structure of botulinum neurotoxin serotype d binding domain |
|
103
|
433
|
3mppG |
Botulinum neurotoxin type g receptor binding domain |
|
45
|
165
|
3k3qC |
Crystal structure of a llama antibody complexed with the c. botulinum neurotoxin serotype a catalytic domain |
|
64
|
249
|
3k3qB |
Crystal structure of a llama antibody complexed with the c. botulinum neurotoxin serotype a catalytic domain |
|
344
|
1251
|
3ffzA |
Domain organization in clostridium butulinum neurotoxin type e is unique: its implication in faster translocation |
|
105
|
421
|
3fuoA |
The crystal structure of receptor binding domain of botulinum neurotoxin serotype a |
|
101
|
411
|
3fuqA |
Glycosylated sv2 and gangliosides as dual receptors for botulinum neurotoxin serotype f |
|
136
|
411
|
3fiiA |
Crystal structure of clostridium botulinum neurotoxin serotype f catalytic domain with an inhibitor (inh2) |
|
135
|
415
|
3fieA |
Crystal structure of clostridium botulinum neurotoxin serotype f catalytic domain with an inhibitor (inh1) |
|
133
|
415
|
3ds9A |
A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than snap-25 substrate |
|
123
|
416
|
3dseA |
A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than snap-25 substrate |
|
336
|
1295
|
3btaA |
Crystal structure of botulinum neurotoxin serotype a |
|
143
|
432
|
3debA |
Crystal structure of apo form (zinc removed) of the botulinum neurotoxin type c light chain |
|
141
|
423
|
3ddaA |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a snap-25 peptide |
|
138
|
423
|
3ddbA |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a substrate analog peptide |
|
138
|
422
|
3c89A |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with inhibitory peptide rrgm |
|
147
|
422
|
3c8aA |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with inhibitory peptide rrgl |
|
136
|
423
|
3c8bA |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with inhibitory peptide rrgi |
